Literature DB >> 28131673

The synergistic effect of vascular cell adhesion molecule-1 and coronary artery disease on brain-derived neurotrophic factor.

I-Te Lee1, Jun-Sing Wang2, Wen-Jane Lee3, Shih-Yi Lin4, Chia-Po Fu5, Kae-Woei Liang6, Chiann-Yi Hsu3, Wayne Huey-Herng Sheu7.   

Abstract

BACKGROUND: Brain-derived neurotrophic factor (BDNF) is important for neural protection and energy homeostasis. In this study, we examined the effects of vascular cell adhesion molecule-1 (VCAM-1) and coronary artery disease (CAD) on BDNF.
METHODS: Subjects who had undergone diagnostic angiography for angina were recruited, and a total of 240 subjects (144 with CAD and 96 without CAD) were enrolled. Serum BDNF was determined at 0, 30, and 120min during an oral glucose tolerance test (OGTT) to calculate the area under the curve (AUC) for BDNF. Serum VCAM-1 was determined at fasting.
RESULTS: Significantly lower AUC of BDNF (42.8±10.7 vs. 47.4±11.7ng-h/ml, P=0.002) and higher serum VCAM-1 (583±383 vs. 482±171ng/ml, P=0.017) were noted in subjects with CAD compared to those without CAD. High VCAM-1 level was an independent predictor of low AUC of BDNF in subjects with and without CAD (95%CI between -0.011 and -0.002, P=0.008; -0.033 and -0.002, P=0.029, respectively). Serum BDNF was lowest in the CAD subjects with high VCAM-1 levels at all time points during OGTT.
CONCLUSION: Our results showed that CAD was associated with low serum BDNF in response to OGTT, and VCAM-1 had a synergistic effect with CAD on the BDNF.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain-derived neurotrophic factor; Coronary artery disease; Oral glucose tolerance test; Vascular cell adhesion molecule-1

Mesh:

Substances:

Year:  2017        PMID: 28131673     DOI: 10.1016/j.cca.2017.01.026

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

Review 1.  Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.

Authors:  Giovanni Lombardi; Veronica Sansoni; Giuseppe Banfi
Journal:  Ann Transl Med       Date:  2017-08

2.  Brain-Derived Neurotrophic Factor Reduces Long-Term Mortality in Patients With Coronary Artery Disease and Chronic Kidney Disease.

Authors:  Cheng-Yueh Hsu; Wayne Huey-Herng Sheu; I-Te Lee
Journal:  Front Cardiovasc Med       Date:  2022-06-21

3.  Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study.

Authors:  Jan K Nowak; Irena Wojsyk-Banaszak; Edyta Mądry; Andrzej Wykrętowicz; Patrycja Krzyżanowska; Sławomira Drzymała-Czyż; Agata Nowicka; Andrzej Pogorzelski; Ewa Sapiejka; Wojciech Skorupa; Mariusz Szczepanik; Aleksandra Lisowska; Jaroslaw Walkowiak
Journal:  Lung       Date:  2017-06-23       Impact factor: 2.584

4.  Serum Renalase Levels Are Predicted by Brain-Derived Neurotrophic Factor and Associated with Cardiovascular Events and Mortality after Percutaneous Coronary Intervention.

Authors:  I-Te Lee; Wayne Huey-Herng Sheu
Journal:  J Clin Med       Date:  2018-11-12       Impact factor: 4.241

5.  Full-Length TrkB Variant in NSCLC Is Associated with Brain Metastasis.

Authors:  Mariangela Lombardi; Michela D'Ascanio; Stefania Scarpino; Davide Scozzi; Marco Giordano; Leopoldo Costarelli; Enrico Rathina Raj; Rita Mancini; Giuseppe Cardillo; Vittorio Cardaci; Marta Innammorato; Andrea Vecchione; Alberto Ricci
Journal:  Biomed Res Int       Date:  2020-11-17       Impact factor: 3.411

6.  Serum brain-derived neurotrophic factor predicting reduction in pulse pressure after a one-hour rest in nurses working night shifts.

Authors:  I-Te Lee; Wayne Huey-Herng Sheu; Wen-Jane Lee; Der-Yuan Chen
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

7.  Brain-Derived Neurotrophic Factor during Oral Glucose Tolerance Test Predicts Cardiovascular Outcomes.

Authors:  I-Te Lee; Yu-Hsuan Li; Wayne Huey-Herng Sheu
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.